Literature DB >> 9477703

[Report of a case of latrodectism occurring in Manaus, Amazonas, Brazil].

A R de Souza1, P F Bührnheim, C S Lima.   

Abstract

In July 2, 1995 arrived at the Instituto de Medicina Tropical do Amazonas as eleven-year-old male with complaining of spider bite on his right retroauricular region, presenting typical findings of latrodectism. The accident was reported as having occurred in the suburbs of Manaus. The patient was given neostigmine preceded by atropine, calcium gluconate, cimetidine, diazepan and hydrocortisone. Within three days the patient showed improvement, and was aware, orientated and with significant palpebral oedema reduction. Muscle spasms are still present, as well as fever, shivering, and intense sweating. In spite of a daily progressive improvement, at the fifth day appeared a spotted papular erythema. The patient was discharged without symptoms after the 13th day. This is the first such reported case which took place in Amazonian region, it might have been happened a consequence of the urban sprawl which has characterized the growth of the city of Manaus, in the last twenty years. It is not possible at this point to evaluate the epidemiological resound of the event, but in any case, it seems plausible to recommend that black widow antivenom become available.

Entities:  

Mesh:

Year:  1998        PMID: 9477703

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  1 in total

1.  Low Health System Performance, Indigenous Status and Antivenom Underdosage Correlate with Spider Envenoming Severity in the Remote Brazilian Amazon.

Authors:  Vanderson Souza Sampaio; André Alexandre Gomes; Iran Mendonça Silva; Jacqueline Sachett; Luiz Carlos Lima Ferreira; Sâmella Oliveira; Meritxell Sabidò; Hipócrates Chalkidis; Maria Graças Vale Barbosa Guerra; Jorge Luis Salinas; Fan Hui Wen; Marcus Vinícius Guimarães Lacerda; Wuelton Marcelo Monteiro
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.